Constitutional mismatch repair deficiency presenting in childhood as three simultaneous malignancies

Andrew W Walter1, Sara Ennis, Hunter Best

  • 1Department of Pediatrics, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania; Department of Pediatrics, A. I. duPont Hospital for Children, Wilmington, Delaware.

Insights

A child with multiple rare cancers had a constitutional mismatch repair deficiency due to a PMS2 gene mutation. This genetic condition explains the simultaneous, aggressive malignancies and impacts family screening.

Area of Science:

  • Oncology
  • Genetics
  • Pediatric Medicine

Background:

  • Constitutional mismatch repair deficiency (CMMR-D) is a rare inherited cancer predisposition syndrome.
  • It is typically associated with Lynch syndrome and an increased risk of early-onset colorectal and other cancers.
  • Simultaneous occurrence of diverse malignancies is exceptionally rare in CMMR-D.

Observation:

  • A 13-year-old female presented with three distinct and aggressive malignancies: glioblastoma multiforme, Burkitt lymphoma, and colonic adenocarcinoma.
  • Despite treatment, the patient's condition progressed, leading to death within 8 months of diagnosis.
  • Genetic testing identified a homozygous mutation in the PMS2 gene.

Findings:

  • The homozygous PMS2 mutation confirmed the diagnosis of constitutional mismatch repair deficiency.
  • Family screening revealed that both parents and three out of four siblings were heterozygous carriers of the PMS2 mutation.
  • The fourth sibling was found to be negative for the mutation.

Implications:

  • This case highlights the extreme phenotypic variability and aggressive nature of CMMR-D, even in pediatric patients.
  • Genetic counseling and cascade screening are crucial for families with confirmed CMMR-D to identify at-risk individuals.
  • Understanding the genetic basis of CMMR-D is vital for developing targeted therapies and improving patient outcomes.

Related Concept Videos

Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair01:36

Mismatch Repair

Overview
Mismatch Repair01:36

Mismatch Repair

Overview
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...